US 10077446
Glucan-encapsulated siRNA for treating type 2 diabetes mellitus
granted A61KA61K31/713A61P
Quick answer
US patent 10077446 (Glucan-encapsulated siRNA for treating type 2 diabetes mellitus) held by The United States of America as Represented by the Secretary, Dept. of Health and Human Services expires Mon Sep 13 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America as Represented by the Secretary, Dept. of Health and Human Services
- Grant date
- Tue Sep 18 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 13 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K31/713, A61P, A61P3/10